Ulcerative Colitis
1,150
141
189
560
Key Insights
Highlights
Success Rate
81% trial completion
Published Results
192 trials with published results (17%)
Research Maturity
560 completed trials (49% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
11.6%
133 terminated out of 1150 trials
80.8%
-5.7% vs benchmark
19%
217 trials in Phase 3/4
34%
192 of 560 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 560 completed trials
Clinical Trials (1150)
Longitudinal Immunophenotyping of Patients With Inflammatory Bowel Disease
A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)
R-3750 in Patients With Mild to Moderate Ulcerative Colitis
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
A Study of Mirikizumab (LY3074828) in Participants With Moderately to Severely Active Ulcerative Colitis
A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the Community Setting
Chronotherapy of 5-Aminosalicylic Acid in Ulcerative Colitis
Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Aquamin® for Prevention of Ulcerative Colitis J-Pouch-associate Intestinal Inflammation
GI Permeability Change in Response to Aquamin®
A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis
An Observational Prospective Long-term Exposure Registry of Adult Patients With Moderate-to-Severe Ulcerative Colitis
Personalized Anti-Inflammatory Fibres in Ulcerative Colitis
A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease
Immune Regulation in Ulcerative Colitis or Crohn s Disease
A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis